Company Filing History:
Years Active: 2020
Title: Israt Shamima Alam: Innovator in Cancer Imaging
Introduction
Israt Shamima Alam is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of cancer research, particularly in the development of non-invasive imaging techniques. Her work focuses on the measurement of pyruvate kinase M2 (PKM2), a crucial enzyme involved in tumor metabolism.
Latest Patents
Israt holds a patent for her invention titled "Imaging tumor glycolysis by non-invasive measurement of pyruvate kinase M2." This patent describes a positron emission tomography (PET)-detectable probe, specifically [F]DASA-23, which selectively binds to the PKM2 variant found in cancer cells, such as those in human glioma. The invention addresses the ongoing need for non-invasive methods to measure PKM2 expression through the development of PKM2-specific radiopharmaceuticals. The patent also includes details on the synthesis of precursors useful for creating the radiolabeled probe.
Career Highlights
Israt Shamima Alam is affiliated with Leland Stanford Junior University, where she continues her research and development efforts. Her innovative work has the potential to significantly impact cancer diagnostics and treatment strategies.
Collaborations
Israt has collaborated with notable colleagues, including Corrine Gaye Beinat and Michelle Louise James. These partnerships enhance her research capabilities and contribute to the advancement of cancer imaging technologies.
Conclusion
Israt Shamima Alam is a trailblazer in the field of cancer imaging, with her patented technology paving the way for improved diagnostic methods. Her contributions are vital in the fight against cancer, showcasing the importance of innovation in medical research.